Related Experiment Videos
Changes in striatal dopamine metabolism during precipitated morphine withdrawal
European Journal of Pharmacology
|August 1, 1977
Summary
Precipitated morphine withdrawal in rats led to increased dopamine (DA) in the striatum. This study suggests a reduction in dopamine release during withdrawal.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- Opioid dependence and withdrawal are significant clinical challenges.
- Understanding the neurochemical changes during withdrawal is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the changes in striatal dopamine (DA) metabolism during precipitated morphine withdrawal.
- To elucidate the role of DA release in the neurobiology of opioid withdrawal.
Main Methods:
- Morphine-tolerant/dependent rats were used to precipitate withdrawal using naloxone or ZK 48491.
- Striatal concentrations of DA, HVA, DOPAC, and 3-methoxytyramine were measured.
- Dopamine synthesis inhibition was assessed following alpha-methyl-p-tyrosine treatment.
Main Results:
- Precipitated withdrawal significantly increased striatal DA concentration.
- Probenecid-induced accumulation of DA metabolites (HVA, DOPAC) was reduced.
- Striatal 3-methoxytyramine levels decreased, while MAO and COMT enzyme activities remained unchanged.
- Naloxone-precipitated withdrawal delayed DA depletion after synthesis inhibition.
Conclusions:
- Results indicate a decreased release of striatal dopamine during precipitated morphine withdrawal.
- This finding contributes to understanding the neurochemical underpinnings of opioid withdrawal syndrome.